IL128786A0 - Use of benzopyranols to treat neurological disorders - Google Patents
Use of benzopyranols to treat neurological disordersInfo
- Publication number
- IL128786A0 IL128786A0 IL12878697A IL12878697A IL128786A0 IL 128786 A0 IL128786 A0 IL 128786A0 IL 12878697 A IL12878697 A IL 12878697A IL 12878697 A IL12878697 A IL 12878697A IL 128786 A0 IL128786 A0 IL 128786A0
- Authority
- IL
- Israel
- Prior art keywords
- benzopyranols
- neurological disorders
- treat neurological
- treat
- disorders
- Prior art date
Links
- SERVTOXIOYSDQO-UHFFFAOYSA-N 2h-chromen-2-ol Chemical class C1=CC=C2C=CC(O)OC2=C1 SERVTOXIOYSDQO-UHFFFAOYSA-N 0.000 title 1
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
| PCT/EP1997/005168 WO1998011890A1 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL128786A0 true IL128786A0 (en) | 2000-01-31 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12878697A IL128786A0 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (de) |
| JP (1) | JP2001500520A (de) |
| KR (1) | KR20000036184A (de) |
| CN (1) | CN1230885A (de) |
| AP (1) | AP9901473A0 (de) |
| AR (1) | AR008838A1 (de) |
| AT (1) | ATE270102T1 (de) |
| AU (1) | AU730465B2 (de) |
| BG (1) | BG103252A (de) |
| BR (1) | BR9712030A (de) |
| CA (1) | CA2266681A1 (de) |
| DE (1) | DE69729735T2 (de) |
| DZ (1) | DZ2311A1 (de) |
| EA (1) | EA199900306A1 (de) |
| ES (1) | ES2223075T3 (de) |
| GB (1) | GB9619492D0 (de) |
| HU (1) | HUP9904638A3 (de) |
| ID (2) | ID23175A (de) |
| IL (1) | IL128786A0 (de) |
| MA (1) | MA24321A1 (de) |
| NO (1) | NO991292D0 (de) |
| NZ (1) | NZ334271A (de) |
| OA (1) | OA10998A (de) |
| PE (1) | PE109898A1 (de) |
| PL (1) | PL332313A1 (de) |
| SK (1) | SK35199A3 (de) |
| TR (1) | TR199900527T2 (de) |
| UY (1) | UY24717A1 (de) |
| WO (1) | WO1998011890A1 (de) |
| ZA (1) | ZA978359B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| US20130281524A1 (en) * | 2008-06-05 | 2013-10-24 | Peter Blower | Novel treatments |
| MX2010013312A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedoos. |
| ES2642586T3 (es) | 2009-07-27 | 2017-11-16 | Gilead Sciences, Inc. | Compuestos heterocíclicos condensados como moduladores de canales iónicos |
| US20130018091A1 (en) * | 2009-12-03 | 2013-01-17 | Peter Blower | Treatment of allodynia and hyperalgesia |
| EP2506847A1 (de) * | 2009-12-03 | 2012-10-10 | Proximagen Limited | Behandlung von infektionserkrankungen |
| EP2588197B1 (de) | 2010-07-02 | 2014-11-05 | Gilead Sciences, Inc. | Kondensierte heterozyklische verbindungen als ionenkanalmodulatoren |
| KR20140033377A (ko) | 2011-05-10 | 2014-03-18 | 길리애드 사이언시즈, 인코포레이티드 | 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물 |
| NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
| UY34171A (es) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal iónico |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| CN1174975C (zh) * | 1994-06-10 | 2004-11-10 | 史密丝克莱恩比彻姆有限公司 | 苯并吡喃类化合物和它们作为治疗剂的用途 |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Withdrawn
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Ceased
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/de not_active Expired - Lifetime
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0939630A1 (de) | 1999-09-08 |
| AR008838A1 (es) | 2000-02-23 |
| AU730465B2 (en) | 2001-03-08 |
| BG103252A (en) | 1999-09-30 |
| DZ2311A1 (fr) | 2002-12-28 |
| HUP9904638A2 (hu) | 2001-05-28 |
| JP2001500520A (ja) | 2001-01-16 |
| EA199900306A1 (ru) | 1999-08-26 |
| PL332313A1 (en) | 1999-08-30 |
| SK35199A3 (en) | 2000-07-11 |
| MA24321A1 (fr) | 1998-04-01 |
| ATE270102T1 (de) | 2004-07-15 |
| CA2266681A1 (en) | 1998-03-26 |
| ZA978359B (en) | 1999-03-17 |
| UY24717A1 (es) | 2001-08-27 |
| HUP9904638A3 (en) | 2001-08-28 |
| AU4704797A (en) | 1998-04-14 |
| PE109898A1 (es) | 1999-03-21 |
| BR9712030A (pt) | 1999-08-24 |
| KR20000036184A (ko) | 2000-06-26 |
| CN1230885A (zh) | 1999-10-06 |
| AP9901473A0 (en) | 1999-03-31 |
| TR199900527T2 (xx) | 1999-06-21 |
| EP0939630B1 (de) | 2004-06-30 |
| ES2223075T3 (es) | 2005-02-16 |
| NO991292L (no) | 1999-03-17 |
| WO1998011890A1 (en) | 1998-03-26 |
| GB9619492D0 (en) | 1996-10-30 |
| ID23175A (id) | 2000-03-23 |
| DE69729735T2 (de) | 2005-07-14 |
| ID19542A (id) | 1998-07-23 |
| DE69729735D1 (de) | 2004-08-05 |
| NO991292D0 (no) | 1999-03-17 |
| NZ334271A (en) | 2001-03-30 |
| OA10998A (en) | 2003-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
| HRP20000201B1 (en) | Prostaglandin agonists and their use to treat bone disorders | |
| PL339425A1 (en) | Treatment of behavioural disorders | |
| EP1063990A4 (de) | Therapie von estrogenabhängigen erkrankungen | |
| IL123601A0 (en) | Use of epinastine for the treatment of pain | |
| EP0729361A4 (de) | Verfahren zur behandlung neurologischer erkrankungen | |
| GB9908175D0 (en) | Method of treating neurological disorders | |
| AU2058697A (en) | Treatment of sleep disorders | |
| ZA958725B (en) | Treatment of disorders with duloxetine | |
| HUP0102923A3 (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss and pharmaceutical compositions containing them | |
| AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
| IL128786A0 (en) | Use of benzopyranols to treat neurological disorders | |
| PL345110A1 (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss | |
| GB9926968D0 (en) | Treatment of neurological disorders | |
| ZA985818B (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders. | |
| IL131347A0 (en) | Treatment of skin disorders | |
| GB9419048D0 (en) | Treatment of muscular disorders | |
| HUP0102886A3 (en) | Treatment of anxiety disorders | |
| HUP9902167A3 (en) | Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system | |
| HK1022628A (en) | Use of benzopyranols to treat neurological disorders | |
| ZA9610134B (en) | The use of 1-hydroxy-2-pyridones for the treatment of mucosal disorders which are difficult to treat | |
| GB9613362D0 (en) | Treatment of neurological and psychiatric disorders | |
| AUPO504297A0 (en) | Treatment of neurological disorders | |
| HK1039319A (en) | Aza-heterocyclic compounds used to treat neurological disorders and hair loss |